Hikal Receives US FDA Warning Letter Over Metal Contamination at Jigani Facility

Hikal; FDA warning letter; metal contamination; API manufacturer; GMP violations; Jigani facility; India; pharmaceutical manufacturing; regulatory compliance

Endo’s Par Pharmaceutical Recalls Blood Pressure Medication Due to Potential Contamination

Endo, Par Pharmaceutical, recall, blood pressure medication, contamination, quinapril HCl/ hydrochlorothiazide tablets, USP 20 mg/12.5 mg, lot number 0KG190092, expiration date 03/2022